BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2549200)

  • 1. Mixed competitive and allosteric antagonism by gallamine of muscarinic receptor-mediated second messenger responses in N1E-115 neuroblastoma cells.
    Lee NH; el-Fakahany EE
    J Neurochem; 1989 Oct; 53(4):1300-8. PubMed ID: 2549200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
    Lee NH; el-Fakahany EE
    J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes.
    Ellis J; Huyler J; Brann MR
    Biochem Pharmacol; 1991 Oct; 42(10):1927-32. PubMed ID: 1741770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different mechanisms of antagonism by methoctramine of two neuronal muscarinic receptor-mediated second messenger responses.
    Lee NH; Fryer AD; Forray C; el-Fakahany EE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):992-9. PubMed ID: 2557423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the interaction of gallamine with muscarinic receptor subtypes.
    Michel AD; Delmendo RE; Lopez M; Whiting RL
    Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
    Dunlap J; Brown JH
    Mol Pharmacol; 1983 Jul; 24(1):15-22. PubMed ID: 6135150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic allosteric modulation: M2/M3 subtype selectivity of gallamine is independent of G-protein coupling specificity.
    Tränkle C; Kostenis E; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):172-8. PubMed ID: 11534857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
    Kenakin T; Boselli C
    J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
    Burke RE
    Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of d-tubocurarine on rat cardiac muscarinic receptors: a comparison with gallamine.
    Waelbroeck M; Robberecht P; De Neef P; Christophe J
    J Recept Res; 1988; 8(6):787-808. PubMed ID: 3193402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gallamine exerts biphasic allosteric effects at muscarinic receptors.
    Ellis J; Seidenberg M
    Mol Pharmacol; 1989 Feb; 35(2):173-6. PubMed ID: 2918854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallamine with brain muscarinic receptors.
    Surichamorn W; Kim ON; Lee NH; Lai WS; el-Fakahany EE
    Neurochem Res; 1988 Dec; 13(12):1183-91. PubMed ID: 3237310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Mediation of separate responses by high affinity and low affinity agonist-receptor conformations.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1985 Feb; 27(2):223-35. PubMed ID: 2982089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
    Ehlert FJ
    J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
    Gillard M; Waelbroeck M; Christophe J
    J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic responses and binding in a murine neuroblastoma clone (N1E-115). Selective loss with subculturing of the low-affinity agonist site mediating cyclic GMP formation.
    McKinney M; Stenstrom S; Richelson E
    Mol Pharmacol; 1984 Sep; 26(2):156-63. PubMed ID: 6148690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a radioalloster to test predictions of the cooperativity model for gallamine binding to the allosteric site of muscarinic acetylcholine M(2) receptors.
    Tränkle C; Weyand O; Schröter A; Mohr K
    Mol Pharmacol; 1999 Nov; 56(5):962-5. PubMed ID: 10531401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
    Franken C; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.
    Narayanan TK; Aronstam RS
    Neurochem Res; 1986 Oct; 11(10):1397-406. PubMed ID: 3785535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.